Physician Wealth Advisors Inc. Has $553,000 Holdings in Huntsman Co. (NYSE:HUN)

Physician Wealth Advisors Inc. grew its holdings in shares of Huntsman Co. (NYSE:HUN) by 27.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 23,676 shares of the basic materials company’s stock after acquiring an additional 5,092 shares during the quarter. Physician Wealth Advisors Inc.’s holdings in Huntsman were worth $553,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Butensky & Cohen Financial Security Inc. grew its holdings in shares of Huntsman by 0.3% during the 2nd quarter. Butensky & Cohen Financial Security Inc. now owns 152,577 shares of the basic materials company’s stock valued at $3,474,000 after purchasing an additional 483 shares during the last quarter. Dumont & Blake Investment Advisors LLC increased its position in Huntsman by 1.7% in the 1st quarter. Dumont & Blake Investment Advisors LLC now owns 30,817 shares of the basic materials company’s stock valued at $802,000 after acquiring an additional 505 shares during the period. GAMMA Investing LLC raised its stake in shares of Huntsman by 44.0% during the first quarter. GAMMA Investing LLC now owns 2,115 shares of the basic materials company’s stock valued at $55,000 after acquiring an additional 646 shares during the last quarter. William Blair Investment Management LLC lifted its holdings in shares of Huntsman by 4.0% during the first quarter. William Blair Investment Management LLC now owns 17,131 shares of the basic materials company’s stock worth $446,000 after purchasing an additional 653 shares during the period. Finally, Quantbot Technologies LP grew its stake in shares of Huntsman by 0.4% in the first quarter. Quantbot Technologies LP now owns 185,005 shares of the basic materials company’s stock worth $4,816,000 after purchasing an additional 693 shares during the last quarter. Institutional investors own 84.81% of the company’s stock.

Huntsman Stock Up 0.6 %

Huntsman stock opened at $23.52 on Thursday. The company has a market capitalization of $4.07 billion, a PE ratio of -45.23 and a beta of 1.00. Huntsman Co. has a 12-month low of $19.91 and a 12-month high of $27.01. The firm’s fifty day moving average is $22.23 and its 200 day moving average is $23.30. The company has a quick ratio of 0.77, a current ratio of 1.30 and a debt-to-equity ratio of 0.40.

Huntsman (NYSE:HUN) last announced its quarterly earnings data on Monday, August 5th. The basic materials company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. The firm had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.61 billion. Huntsman had a negative net margin of 1.44% and a positive return on equity of 0.26%. The business’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.22 earnings per share. As a group, sell-side analysts predict that Huntsman Co. will post 0.19 EPS for the current fiscal year.

Huntsman Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Friday, September 13th were paid a $0.25 dividend. The ex-dividend date of this dividend was Friday, September 13th. This represents a $1.00 dividend on an annualized basis and a yield of 4.25%. Huntsman’s dividend payout ratio (DPR) is presently -192.31%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HUN. Royal Bank of Canada raised their target price on Huntsman from $21.00 to $24.00 and gave the stock a “sector perform” rating in a research report on Friday, October 11th. Wells Fargo & Company cut their price objective on Huntsman from $28.00 to $26.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 7th. JPMorgan Chase & Co. decreased their target price on shares of Huntsman from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, August 7th. UBS Group lowered their price target on shares of Huntsman from $23.00 to $22.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. Finally, Citigroup reduced their price objective on shares of Huntsman from $26.00 to $24.00 and set a “neutral” rating on the stock in a research note on Thursday, June 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $25.89.

Huntsman Company Profile

Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.